Skip to main content

Table 2 Model parameter ranges for the sensitivity analysis

From: Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar

Community engagement Default Maximum Minimum Comments
Number of days spent in a village for CE 1 3 0.5 METF trial
Number of staff in a team 3 8 2 METF trial
Consumables 18 20.7 15.3 +/−15%
Refreshments 19 21.85 16.15 +/−15%
Number of villages provided with a community incentive 3 4 0 Assumption
Cost of community incentives 4828 5000 4103.8 +/−15%
Percentage of villages for CE 5% 10% 0 Assumption
Number of training sessions 4 5 1 Assumption
Number of participants in one training session 10 40 8 Assumption
Number of trainers in one training session 2 3 1 Assumption
Duration of training session 3 5 1 METF trial
Number of trips to a village for community engagement 3 5 1 METF trial
Identification of targeted MDA villages Default Maximum Minimum Comments
Percentage of villages surveyed to identify hotspot villages 22 25.3 18.7 +/− 15%
Number of days spent in a village for uPCR 1 1.5 0.5 METF trial
Staff involved 4 5 2 METF trial
Incentive for one participant 1 2 0 METF trial
Equipment 5 9.25 4.25 +/−15%
Consumables 1 1.15 0.85 +/− 15%
uPCR analysis cost 25 40 15 METF trial
Number of training sessions 6 7 3 Assumption
Number of participants 20 20 10 Assumption
Number of trainers 2 3 1 Assumption
Duration of training sessions 1 2 0.5 METF trial
Monitoring trip 1 2 0 Assumption
Number of days spent in a village for monitoring 5 10 2 Assumption
Mass treatment Default Maximum Minimum Comments
Percentage of villages that are offered targeted MDA activity 5% 10% 1% Assumption
Number of targeted MDA rounds in a year 3 5 1 Assumption
Average percentage of population coverage for targeted MDA in a round 70% 80.5% 59.5% +/− 15%
Number of days spent in a village for targeted MDA activity 7 9 5 METF trial
Incentive for one participant in a round for targeted MDA 1 2 0 Assumption
Number of trips requiring car rental during targeted MDA activity 15 15 8 METF trial
Equipment cost per village 25 28.75 21.25 +/− 15%
Consumables cost per village 11 12.65 9.35 +/− 15%
Cost of ACT child 0.93 1.0695 0.7905 +/− 15%
Cost of ACT youth 1.46 1.679 1.241 +/−15%
Cost of ACT adult 1.98 2.277 1.683 +/−15%
Cost of primaquine 0.01 0.0115 0.0085 +/− 15%
Cost of medicine for treatment of side-effects per village 39 44.85 33.15 +/− 15%
Antimalarial drug wastage 5 10 3 Assumption
Number of training sessions 5 7 2 Assumption
Number of participants 20 50 15 Assumption
Number of trainers 3 5 2 Assumption
Duration of training sessions 3 5 1 METF trial
Number of monitoring trips 1 3 0 Assumption
Duration of monitoring trips 10 15 5 Assumption
  1. MDA Mass drug administration; uPCR Ultrasensitive polymerase chain reaction; ACT Artemisinin Combination Therapy; METF Malaria Elimination Task Force